In Committee from the Senate of Canada - Social Affairs, Science and Technology - January 29, 2014
The committee begins a new phase in its four-part study of prescription pharmaceuticals in Canada. The next few hearings will focus on the nature of unintended consequences of pharmaceuticals.
Dr. Ingrid Sketris from the Health Council of Canada speaks about the role of health care professionals and steps to improve the safety, effectiveness and affordability of drug therapies for Canadians.
Canadian Patient Safety Institute representatives Hugh MacLeod and Emily Musing discuss their concerns with the prescription pharmaceutical system and outline recommendations to improve it. (January 29, 2014)